These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 25606362)

  • 41. Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex.
    Arsenault J; Hooper AWM; Gholizadeh S; Kong T; Pacey LK; Koxhioni E; Niibori Y; Eubanks JH; Wang LY; Hampson DR
    Hum Mol Genet; 2021 Feb; 29(23):3744-3756. PubMed ID: 33084871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome.
    Tabolacci E; Palumbo F; Nobile V; Neri G
    Genes (Basel); 2016 Aug; 7(8):. PubMed ID: 27548224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of FMRP Impaired Hippocampal Long-Term Plasticity and Spatial Learning in Rats.
    Tian Y; Yang C; Shang S; Cai Y; Deng X; Zhang J; Shao F; Zhu D; Liu Y; Chen G; Liang J; Sun Q; Qiu Z; Zhang C
    Front Mol Neurosci; 2017; 10():269. PubMed ID: 28894415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fragile X syndrome: A review of clinical management.
    Lozano R; Azarang A; Wilaisakditipakorn T; Hagerman RJ
    Intractable Rare Dis Res; 2016 Aug; 5(3):145-57. PubMed ID: 27672537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
    Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
    Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cochlear Nucleus Transcriptome of a Fragile X Mouse Model Reveals Candidate Genes for Hyperacusis.
    Sakano H; Castle MS; Kundu P
    Laryngoscope; 2024 Mar; 134(3):1363-1371. PubMed ID: 37551886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.
    Martinez LA; Tejada-Simon MV
    Mol Neurobiol; 2018 Jun; 55(6):4529-4542. PubMed ID: 28688003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progranulin is an FMRP target that influences macroorchidism but not behaviour in a mouse model of Fragile X Syndrome.
    Life B; Bettio LEB; Gantois I; Christie BR; Leavitt BR
    Curr Res Neurobiol; 2023; 5():100094. PubMed ID: 37416094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in insulin-like growth factor signaling alter phenotypes in Fragile X Mice.
    Wise TL
    Genes Brain Behav; 2017 Feb; 16(2):241-249. PubMed ID: 27643697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
    Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
    J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.
    Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF
    Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection and Quantification of the Fragile X Mental Retardation Protein 1 (FMRP).
    LaFauci G; Adayev T; Kascsak R; Brown WT
    Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27941672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synaptic vesicle dynamic changes in a model of fragile X.
    Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
    Mol Autism; 2016; 7():17. PubMed ID: 26933487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome.
    Qin M; Huang T; Kader M; Krych L; Xia Z; Burlin T; Zeidler Z; Zhao T; Smith CB
    Int J Neuropsychopharmacol; 2015 Mar; 18(9):. PubMed ID: 25820841
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Fyke W; Velinov M
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fragile X Syndrome: Lessons Learned and What New Treatment Avenues Are on the Horizon.
    Hagerman RJ; Hagerman PJ
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():365-381. PubMed ID: 34499526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translational endpoints in fragile X syndrome.
    de Esch CE; Zeidler S; Willemsen R
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():256-69. PubMed ID: 24184744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study.
    Brašić JR; Goodman JA; Nandi A; Russell DS; Jennings D; Barret O; Martin SD; Slifer K; Sedlak T; Mathur AK; Seibyl JP; Berry-Kravis EM; Wong DF; Budimirovic DB
    Brain Sci; 2022 Feb; 12(3):. PubMed ID: 35326270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.
    Santos AR; Kanellopoulos AK; Bagni C
    Learn Mem; 2014 Oct; 21(10):543-55. PubMed ID: 25227249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.